These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30029060)

  • 61. The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease.
    Davtyan H; Ghochikyan A; Cadagan R; Zamarin D; Petrushina I; Movsesyan N; Martinez-Sobrido L; Albrecht RA; García-Sastre A; Agadjanyan MG
    J Transl Med; 2011 Aug; 9():127. PubMed ID: 21806809
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1.
    Buckwalter MS; Coleman BS; Buttini M; Barbour R; Schenk D; Games D; Seubert P; Wyss-Coray T
    J Neurosci; 2006 Nov; 26(44):11437-41. PubMed ID: 17079673
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
    Schiltz JG; Salzer U; Mohajeri MH; Franke D; Heinrich J; Pavlovic J; Wollmer MA; Nitsch RM; Moelling K
    J Mol Med (Berl); 2004 Oct; 82(10):706-14. PubMed ID: 15241501
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Peptide Vaccine Combined with Prior Immunization of a Conventional Diphtheria-Tetanus Toxoid Vaccine Induced Amyloid β Binding Antibodies on Cynomolgus Monkeys and Guinea Pigs.
    Yano A; Ito K; Miwa Y; Kanazawa Y; Chiba A; Iigo Y; Kashimoto Y; Kanda A; Murata S; Makino M
    J Immunol Res; 2015; 2015():786501. PubMed ID: 26539559
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.
    Qu B; Rosenberg RN; Li L; Boyer PJ; Johnston SA
    Arch Neurol; 2004 Dec; 61(12):1859-64. PubMed ID: 15596606
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MHC-independent genetic factors control the magnitude of CD4+ T cell responses to amyloid-β peptide in mice through regulatory T cell-mediated inhibition.
    Toly-Ndour C; Lui G; Nunes MM; Bruley-Rosset M; Aucouturier P; Dorothée G
    J Immunol; 2011 Nov; 187(9):4492-500. PubMed ID: 21949026
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immune shaping and the development of Alzheimer's disease vaccines.
    Federoff HJ; Bowers WJ
    Sci Aging Knowledge Environ; 2005 Nov; 2005(46):pe35. PubMed ID: 16293586
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HSV amplicon-mediated Abeta vaccination in Tg2576 mice: differential antigen-specific immune responses.
    Bowers WJ; Mastrangelo MA; Stanley HA; Casey AE; Milo LJ; Federoff HJ
    Neurobiol Aging; 2005 Apr; 26(4):393-407. PubMed ID: 15653168
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage.
    Nikolic WV; Bai Y; Obregon D; Hou H; Mori T; Zeng J; Ehrhart J; Shytle RD; Giunta B; Morgan D; Town T; Tan J
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2507-12. PubMed ID: 17264212
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.
    Lambert MP; Viola KL; Chromy BA; Chang L; Morgan TE; Yu J; Venton DL; Krafft GA; Finch CE; Klein WL
    J Neurochem; 2001 Nov; 79(3):595-605. PubMed ID: 11701763
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rationale for peptide and DNA based epitope vaccines for Alzheimer's disease immunotherapy.
    Ghochikyan A
    CNS Neurol Disord Drug Targets; 2009 Apr; 8(2):128-43. PubMed ID: 19355933
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stimulation Effects and Mechanisms of Different Adjuvants on a Norovirus P Particle-Based Active Amyloid-β Vaccine.
    Dai M; Feng X; Mo Z; Sun Y; Fu L; Zhang Y; Wu J; Yu B; Zhang H; Yu X; Wu H; Kong W
    J Alzheimers Dis; 2020; 77(4):1717-1732. PubMed ID: 32925038
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Delivery of a DNA vaccine for Alzheimer's disease by electroporation versus gene gun generates potent and similar immune responses.
    Davtyan H; Ghochikyan A; Movsesyan N; Ellefsen B; Petrushina I; Cribbs DH; Hannaman D; Evans CF; Agadjanyan MG
    Neurodegener Dis; 2012; 10(1-4):261-4. PubMed ID: 22301697
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Active immunotherapy facilitates Aβ plaque removal following through microglial activation without obvious T cells infiltrating the CNS.
    Sha S; Xing XN; Cao YP
    J Neuroimmunol; 2014 Sep; 274(1-2):62-70. PubMed ID: 25087756
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β.
    Song G; Yang H; Shen N; Pham P; Brown B; Lin X; Hong Y; Sinu P; Cai J; Li X; Leon M; Gordon MN; Morgan D; Zhang S; Cao C
    J Alzheimers Dis; 2020; 77(4):1639-1653. PubMed ID: 32925044
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multiple Antigenic Peptide System Coupled with Amyloid Beta Protein Epitopes As An Immunization Approach to Treat Alzheimer's Disease.
    Sun D; Qiao Y; Jiang X; Li P; Kuai Z; Gong X; Liu D; Fu Q; Sun L; Li H; Ding J; Shi Y; Kong W; Shan Y
    ACS Chem Neurosci; 2019 Jun; 10(6):2794-2800. PubMed ID: 31042358
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Novel Aβ B-Cell Epitope Vaccine (rCV01) for Alzheimer's Disease Improved Synaptic and Cognitive Functions in 3 × Tg-AD Mice.
    Yu YZ; Liu S; Wang HC; Shi D; Xu Q; Zhou XW; Sun ZW; Huang PT
    J Neuroimmune Pharmacol; 2016 Dec; 11(4):657-668. PubMed ID: 27147259
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation.
    Xing X; Sha S; Li Y; Zong L; Jiang T; Cao Y
    J Neurol Sci; 2012 Feb; 313(1-2):17-21. PubMed ID: 22029939
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
    Panza F; Logroscino G; Imbimbo BP; Solfrizzi V
    Curr Opin Psychiatry; 2014 Mar; 27(2):128-37. PubMed ID: 24445401
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preparation and in vitro activity of single chain antibodies against Alzheimer's disease.
    Fu L; Zhang Y; Zhang X; Tian W; Zhang W; Jia Y; Zhang L
    Immunol Lett; 2020 Nov; 227():1-7. PubMed ID: 32781005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.